Cargando…
Saturation monitoring of VX15/2503, a novel semaphorin 4D‐specific antibody, in clinical trials
BACKGROUND: Receptor occupancy, or saturation, assays are often utilized in preclinical and clinical development programs to evaluate the binding of a biologic to a cellular target. These assays provide critical information regarding the dose of drug required to “saturate” the target as well as impo...
Autores principales: | Fisher, Terrence L., Seils, Jennifer, Reilly, Christine, Litwin, Virginia, Green, Lisa, Salkowitz‐Bokal, Janelle, Walsh, Robin, Harville, Sarah, Leonard, John E., Smith, Ernest, Zauderer, Maurice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064733/ https://www.ncbi.nlm.nih.gov/pubmed/26566052 http://dx.doi.org/10.1002/cyto.b.21338 |
Ejemplares similares
-
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trial
por: LaGanke, Christopher, et al.
Publicado: (2017) -
Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity
por: Evans, Elizabeth E., et al.
Publicado: (2022) -
Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D
por: Evans, Elizabeth E, et al.
Publicado: (2015) -
PB2503: MODULATION OF ERYTHROCYTE FUNCTION BY ENDOTHELIN-1
por: Teixeira-Alves, Lyzes Rosa, et al.
Publicado: (2023) -
Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations
por: Evans, Elizabeth E, et al.
Publicado: (2015)